Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 Mar;37(3):434-47.
doi: 10.1038/bjc.1978.64.

Management of trials in the development of cancer chemotherapy

C J Williams, S K Carter
Free PMC article

Management of trials in the development of cancer chemotherapy

C J Williams et al. Br J Cancer. 1978 Mar.
Free PMC article

Abstract

Potential anti-cancer agents have classically undergone clinical assessment in Phase I, II and III trials. This paper examines the role of these trials and pre-clinical studies in the light of improving cancer chemotherapy. Many patients must now be treated with standard therapy before investigational drugs can be ethically used. The introduction of combined modality trials will require a very prolonged follow-up to demonstrate improved survival and recognize late onset of chronic toxicity.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Assessing clinical trials--restricted randomisation.
    Gore SM. Gore SM. Br Med J (Clin Res Ed). 1981 Jun 27;282(6282):2114-7. doi: 10.1136/bmj.282.6282.2114. Br Med J (Clin Res Ed). 1981. PMID: 6788226 Free PMC article. Clinical Trial. No abstract available.
  • Cancer chemotherapy.
    Wrighton RJ. Wrighton RJ. J R Soc Med. 1979 Jan;72(1):1-2. doi: 10.1177/014107687907200101. J R Soc Med. 1979. PMID: 552411 Free PMC article. No abstract available.
  • Clinical relevance of pharmacokinetics.
    Tognoni G, Bellantuono C, Bonati M, D'Incalci M, Gerna M, Latini R, Mandelli M, Porro MG, Riva E. Tognoni G, et al. Clin Pharmacokinet. 1980 Mar-Apr;5(2):105-36. doi: 10.2165/00003088-198005020-00001. Clin Pharmacokinet. 1980. PMID: 6102499 Review. No abstract available.
  • Phase I evaluation of divided-dose vinblastine sulfate.
    Schulman P, Budman DR, Vinciguerra V, Degnan TJ. Schulman P, et al. Cancer Chemother Pharmacol. 1980;5(1):67-9. doi: 10.1007/BF00578565. Cancer Chemother Pharmacol. 1980. PMID: 7460196

References

    1. J Chronic Dis. 1962 Mar;15:223-8 - PubMed
    1. Cancer Chemother Rep. 1962 Feb;16:99-105 - PubMed
    1. Cancer Res. 1958 Aug;18(7):853-6 - PubMed
    1. Br J Cancer. 1976 Dec;34(6):585-612 - PubMed
    1. Eur J Cancer. 1973 Nov-Dec;9(11-12):833-41 - PubMed

Substances